Clinical trial
Comparison of the Atmo Motility Gas Capsule System to the Reference Standard (SmartPill) for Gastrointestinal Transit Time Measures in Patients With Functional Gastrointestinal Symptoms and Dysmotility
NCT05718505 is registered in ClinicalTrials.gov with Atmo Biosciences Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Atmo Motility Gas Capsule System to the Reference Standard (SmartPill) for Gastrointestinal Transit Time Measures in Patients With Functional Gastrointestinal Symptoms and Dysmotility
- Lead sponsor
- Atmo Biosciences Pty Ltd
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 5, 2023
- Completion date
- April 30, 2024
- Enrollment
- 209 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
gastroparesis, ibs, slow transit constipation